Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
75
Warrant Exposure
40
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 43%
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 31% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
model 38%
• Active shelf registration ($400M, 323% of market cap)
• Active ATM program with $100M remaining capacity
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (63/100)
Market Data
Market Cap$123.93M
Shares Outstanding66.99M
Float22.49M
Cash$258.46M
Debt$33.46M
Short InterestN/A
Institutional Holdings
10 institutional holders · 42.50M shares
#1
FCPM III Services B.V.
9.63M shares
#2
Perceptive Advisors Llc
5.87M shares
#3
VR Adviser, LLC
4.77M shares
+ 7 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest1.73M
Days to Cover2.5
% of Float7.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2024-10-31
xbrl
XBRL CONVERTIBLE
2023-10-31
424B5
ATM
2026-03-09
8-K
8K EVENT
2026-03-09
EFFECT
EFFECT
2026-03-02
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual ENGN Dilution Snapshot
enGene Therapeutics Inc. (ENGN) has a DilutionScore of 63/100, rated High dilution risk. Score date: August 28, 2026.
- Stored shelf registration capacity: $400.0M.
- Stored ATM program remaining capacity: $100.0M.
- Recent SEC activity tracked for ENGN: 424B5 on 2026-03-09; 8-K on 2026-03-09; EFFECT on 2026-03-02.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: